Pfizer, BioNTech start COVID-flu combination vaccine study
Summary by Reuters
U.S. drugmaker Pfizer Inc (PFE.N) and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.Published 3 months ago · New York, United States
News Articles
More Filters
All
Left
Center
Right
Similar News Topics
Time & Location
Sources are mostly out of (0)